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ABSTRACT The objective of this study was to clarify the
relative roles of medial versus luminal factors in the induction
of thickening of the arterial intima after balloon angioplasty
injury. Platelet-derived growth factor (PDGF) and thrombin,
both associated with thrombosis, and basic fibroblast growth
factor (bFGF), stored in the arterial wall, have been impli-
cated in this process. To unequivocally isolate the media from
luminally derived factors, we used a 20-mm thick hydrogel
barrier that adhered firmly to the arterial wall to block
thrombus deposition after balloon-induced injury of the ca-
rotid artery of the rat. Thrombosis, bFGF mobilization,
medial repopulation, and intimal thickening were measured.
Blockade of postinjury arterial contact with blood prevented
thrombosis and dramatically inhibited both intimal thicken-
ing and endogenous bFGF mobilization. By blocking blood
contact on the two time scales of thrombosis and of intimal
thickening, and by using local protein release to probe, by
reconstitution, the individual roles of PDGF-BB and throm-
bin, we were able to conclude that a luminally derived factor
other than PDGF or thrombin is required for the initiation of
cellular events leading to intimal thickening after balloon
injury in the rat. We further conclude that a luminally derived
factor is required for mobilization of medial bFGF.
Complications of arterial wound healing greatly limit the efficacy
of procedures to re-open obstructed arteries. Intimal thickening,
which involves the migration and proliferation of smooth muscle
cells (SMCs) in the arterial wall and the overproduction of matrix
proteins (1), may contribute to these complications. We and
others have previously reported the use of thin intravascular
hydrogel barriers for the prevention of thrombosis in the rabbit
after balloon injury (2) and in the pig after stent deployment (3,
4). The biocompatible barriers, formed via in situ interfacial
photopolymerization of a polyethylene glycol (PEG)-based pre-
cursor, adhere to the vessel wall and block deposition of blood
cells after injury. We sought to use this ability to unequivocally
isolate the arterial wall from blood after injury to investigate the
role of thrombus-derived factors, such as platelet-derived growth
factor (PDGF) and thrombin, in initiating the cascade of events
that leads to intimal thickening after arterial injury. This was
accomplished using barrier materials that remained on the artery
for either the time scale of thrombosis or of intimal thickening,
and also using perivascular materials to reconstitute platelet-
derived factors by local release.
Thrombus adherent to the arterial intima after injury may
provide multiple signals for intimal thickening. PDGF is released
from the a-granules of platelets upon activation and is a SMC
chemotactic factor andmitogen. PDGFhas been shown to induce
intimal thickening after balloon injury in the rat (5), primarily by
induction of SMC migration and matrix elaboration (6). Throm-
bin, generated by the prothrombinase complex on activated
platelets, is a SMC mitogen and stimulates SMC matrix elabo-
ration (7, 8). Administration of a thrombin inhibitor has been
shown to reduce intimal thickening after balloon injury in the
rabbit (9). The platelet–fibrin thrombus may also serve as a
physical matrix for SMC migration (10).
Factors intrinsic to the arterial media may also stimulate
intimal thickening. Basic fibroblast growth factor (bFGF) is
present in the normal arterial media, both intracellularly and
bound in inactive form to heparan sulfate proteoglycan in the
extracellular matrix (11, 12). bFGF has been shown to promote
SMC chemotaxis and proliferation. Local delivery of bFGF after
balloon injury in the rat greatly increased intimal thickening and
SMC proliferation (13). Treatment with bFGF neutralizing an-
tibodies after arterial injury decreased SMC proliferation by
'80%, yet did not significantly affect intimal thickening (14).
In spite of many important insights into the biological re-
sponses induced by individual factors involved in arterial healing,
the relationship between these factors following injury remains
unclear. One reason for this is the difficulty in separating blood-
derived factors from vessel wall-derived factors following injury.
We now report an investigation of the relative roles of luminal
versus medial factors in arterial healing using a novel approach to
physically separate the vessel wall from the lumen.
MATERIALS AND METHODS
Rat Balloon Injury Model. A balloon-induced deendothelial-
ization and stretch injury to the carotid artery of the rat was used
as an experimental model somewhat analogous to balloon an-
gioplasty, although the injury created is more severe than that in
the clinical situation. In addition, the adventitia was removed
from the arterial wall in this model; while this may impact arterial
healing, the rat has minimal vasa vasorum and thus the effect
would be expected to be small. Male Sprague Dawley rats
(300–400 g) were anesthetized i.p. with pentobarbital (50 mgy
kg). The left carotid artery was surgically exposed, and micro-
surgical clamps were applied to the internal, external, and com-
mon carotid arteries to isolate a zone in the common carotid
artery. The adventitia was dissected from the zone, and bloodwas
removed by rinsing with Hepes-buffered saline (HBS; pH 7.4, 10
mM). A balloon injury was subsequently created by passing an
inflated 2F Fogarty catheter through the common carotid artery
zone three times. Animals were randomly assigned to treatment
and control groups after injury. Immediately after injury but
before reexposure to blood flow, the appropriate treatment was
applied as described below. Control animals received no treat-
ment. Additional control groups received application of the
hydrogel barrier without balloon injury to determine if the
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photopolymerization process or the prolonged presence of the
hydrogel barrier caused morphological changes in the vessel wall;
blood was rinsed from the carotid arteries prior to hydrogel
treatment. Rats were killed by CO2 asphyxiation at the prede-
termined time points, and the carotid arteries were rinsed with
HBS, fixed with 10% buffered formalin under perfusion, and
then explanted and prepared for histological analysis. All animal
experimentationwas approved by theUniversity of TexasAnimal
Care and Use Committee.
Interfacial Photopolymerization. The hydrogel barrier was
formed on the balloon-injured arterial wall of the rat via inter-
facial photopolymerization (2, 15). Following balloon injury, a
PE-10 polyethylene tube was inserted as a catheter through the
external carotid artery to the common carotid artery to introduce
fluids to the artery. The carotid zone was flushed with a tissue-
adsorbing photoinitiator, eosin Y (1 mM in HBS), for 30 sec.
Excess eosin Y was rinsed with HBS, and the region was filled
with a solution of PEG diacrylate (PEG-DA; nondegradable) or
PEG-co-polylactic acid diacrylate (PEG-L-DA; degradable)
(both 23%) with cocatalysts triethanolamine (100 mM) and
N-vinylpyrrolidone (1500 ppm) in HBS and illuminated with a
xenon arc lamp [Optomed, Austin, TX; 400–600 nm, 35 mWycm
(2), 30 sec for PEG-DA or 10 sec for PEG-L-DA]. All solutions
were sterilized by filtration (0.2mm). The interfacial nature of the
photopolymerization process, with the initiator adsorbed to the
arterial wall, constrained formation of the hydrogel to the intimal
surface. The catheter was removed, and the external carotid
artery was ligated with a 5-0 silk suture. In control experiments,
the hydrogel barrier was applied to noninjured arteries.
Determination of Hydrogel Thickness and Degradation Ki-
netics. Fluorescent beads (1 mm diameter, Polysciences) were
mixed into the precursor formulation and became entrapped
within the resulting gel, aiding in visualization as described
previously (2). The hydrogel barrier was formed by interfacial
photopolymerization of PEG-DA or PEG-L-DA as described
above in noninjured animals. Animals were killed at predeter-
mined time points byCO2 asphyxiation, and the left carotid artery
was immediately explanted and rinsed. The vessels were cryo-
sectioned and visualized by fluorescence microscopy. Digital
image analysis (Hamamatsu,Middlesex, NJ) was used tomeasure
the thickness of the hydrogel barrier at eight equally spaced angles
around the artery.
Local Release of PDGF and Thrombin. PEG-L-DA (23%) was
dissolved in solutions of PDGF (BB form, 620 mgyml, Sigma),
thrombin (9.3 unitsyml, Sigma), or HBS (control), each of which
also contained 0.1 mM eosin Y, 100 mM triethanolamine, and
1500 ppm N-vinylpyrrolidone. All solutions were sterilized by
filtration (0.2 mm). A balloon injury was created as described
above, after which assignment to a treatment grouping wasmade.
If appropriate for the given treatment group, a PEG-DA barrier
was applied by interfacial photopolymerization before reexpo-
sure to blood flow, and 100 ml of the appropriate PEG-L-DA
solution was applied to the outside of the common carotid artery.
The liquid precursor was converted to a hydrogel by exposure to
a xenon arc lamp [20 mWycm (2), 30-sec exposure]. Controls
consisted of animals lacking the intimal PEG-DA barrier or
lacking PDGF-BB or thrombin in the perivascular PEG-L-DA
hydrogel. At 14 days, the rats were killed, and the arteries were
fixed and explanted as described above and then prepared for
histological analysis. The quantities of PDGF-BB and thrombin
that were delivered were based on approximately twice the
amount contained within a thrombus 50 mm thick (15, 16).
Histological Analysis. Histological staining was used to quan-
tify thrombosis, intimal thickening, total cells in the media, and
inflammatory cells in the media. To assess the extent of throm-
bosis, sections were stained with hematoxylin and eosin, and the
thickness of the thrombus was measured at eight equally spaced
angles around the artery. To assess the extent of intimal thick-
ening, sections were stained with van Gieson’s elastin stain; the
cross-sectional areas of the intima (all tissue internal to the
internal elastic lamina) and the media were measured by digital
image analysis (Hamamatsu). To determine the total number of
cells in the media, sections were stained with hematoxylin and
eosin, and all cell nuclei in themedia were counted. To determine
the number of inflammatory cells in the media, sections were
stained with Giemsa stain, and Giemsa-positive cells were
counted; any preferential localization of Giemsa-positive cells
was noted.
Immunohistochemical staining was used to identify medial
SMCs. Sections were deparaffinized, rehydrated, and partially
digested with trypsin (0.1 mgyml, 10 min). Sections were
incubated in 10 mgyml BSA for 1 hr and then in mouse
anti-SMC actin IgG (Dako, 1:100) for 6 hr. After thorough
rinsing, the sections were incubated in horseradish peroxidase-
conjugated goat anti-mouse IgG (Dako, 1:100) for 2 hr and
then developed with diaminobenzidine (Sigma). A cell nucleus
(by hematoxylin counterstain) not within one nuclear diameter
of SMC actin-positive staining was judged to be other than a
SMC.
bFGF Depletion. Arteries were balloon injured and treated
with the PEG-DA hydrogel barrier as described above. On day 4,
the rats were killed by CO2 asphyxiation, and the left (injured)
and right (not injured or treated) carotid arteries were prepared
for assay of bFGF exactly as described (17). Bloodwas thoroughly
rinsed from the segments, and the tissue was frozen in liquid
nitrogen and ground with mortar and pestle to form a fine
powder. This powder was resuspended in 1% SDS containing 0.2
mgyml EDTA, 1 mM phenylmethylsulfonyl fluoride, and 10
mgyml leupeptin (each from Sigma). Particulate matter was
removed by centrifuging at 10,000 3 g for 5 min. Total protein
concentration in each sample was determined by BCA assay
(Pierce). bFGF levels (relative to total protein) weremeasured by
ELISA using a mouse anti-human bFGF IgG (which cross reacts
with rat bFGF, Sigma), a HRP-conjugated goat anti-mouse IgG
(Sigma), and 3,39,5,59-tetramethylbenzidine as the horseradish
peroxidase substrate (Pierce).
Precursor Synthesis. PEG-L-DA was synthesized as described
previously (2). Briefly, PEG (10,000 Da) was dried by azeotropic
distillation in toluene. A 7-fold molar excess (based on end-
groups) of DL-lactide and equimolar stannous octoate were
added to the polymer solution. The mixture was refluxed under
argon for 16 hr and cooled to room temperature; PEG-L was
precipitated with hexane, filtered, washed, and dried. The PEG-L
was then dissolved in tetrahydrofuran and reacted with a 5-fold
molar excess of acryloyl chloride and a 5-fold molar excess of
triethylamine for 24 hr under argon at room temperature. The
mixture was filtered, and the PEG-L-DA was precipitated with
cold ether, filtered, washed, and dried. PEG-L-DA was stored at
2208C under argon until use.
PEG-DA was synthesized as described (18). Briefly, PEG
(10,000 Da) was dried by azeotropic distillation, dissolved in
tetrahydrofuran and reacted with a 5-foldmolar excess of acryloyl
chloride and a 5-fold molar excess of triethyl amine for 24 hr
under argon. The mixture was filtered, and the PEG-DA was
precipitated with cold ether, filtered, washed, and dried.
RESULTS
Stability of theHydrogel Barrier.The stability of the PEG-DA
hydrogel barrier (nondegradable)was examined in noninjured rat
carotid arteries after cryosectioning. The thickness of the barrier
can be controlled via the duration of illumination (2): a thickness
of 196 7mm (mean6 SEM, n5 4) was obtained by illumination
for 30 sec at 35 mWycm (2) with PEG-DA. The thickness of the
PEG-DA hydrogel barrier did not change significantly over 28 d
in vivo (19 6 7 mm prior to blood flow versus 16 6 6 mm at day
28,mean6 SEM, n5 4 per group,P. 0.5 by theMann–Whitney
U test).
Degradation of the PEG-L-DA hydrogel barrier was assessed
by monitoring the disappearance of the barrier over time. The
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initial thickness of the PEG-L-DA barrier was 16 6 4 mm
(mean 6 SEM, n 5 4 per group). At 6 hr, the thickness was
reduced to 13 6 2 mm, and at 12 hr the hydrogel formed a
continuous barrier with a thickness of 8 6 4 mm. At 24 hr, the
hydrogel barrier could no longer be detected on the arterial wall.
Thrombosis, Intimal Thickening, and Medial Repopulation.
Blood contact was prohibited after balloon injury by applying the
hydrogel barrier prior to reexposure to blood flow. This process
altered both thrombosis and intimal thickening. Thrombosis was
completely prevented by application of the nondegradable hy-
drogel barrier while control vessels consistently displayed mural
thrombosis with an average thickness of 496 23 mm (P, 0.005)
at 2 hr (Fig. 1 A and B). In vessels treated with the degradable
PEG-L-DA barrier, present on the arterial wall for '24 hr,
thrombosis was completely prevented as measured 2 hr following
injury. The presence and time course of thrombosis following
degradation of the PEG-L-DA barrier was not examined. The
long-term healing outcome of intimal thickening was histologi-
cally assessed at 14 and 28 days (Table 1; Fig. 1 C and D).
Blockade of blood contact with the nondegradable PEG-DA
FIG. 1. Histology of rat carotid arteries after balloon injury and various treatments as described below. All barriers were nondegradable and
remained adherent to the artery wall for the duration of the experiment. The hydrogel barrier cannot be observed in these sections due to the
dehydration process. Staining was by hematoxylin and eosin. Black arrows denote the location of the internal elastic lamina. (Bar 5 50 mm.) (A)
Control vessel 2 hr after injury. Platelet deposition can be clearly noted above the two arrowheads. (B) Hydrogel-treated vessel 2 hr after injury.
No platelet deposition could be noted by light microscopy. (C) Control vessel 28 days after injury. The formation of a fibrocellular neointima is
clearly evident above the two arrowheads. (D) Hydrogel-treated vessel 28 days after injury. Isolation from blood contact prevented neointima
formation and slowed repopulation of the media. (E) Vessel 14 days after injury, with local delivery of PDGF but without blockade of blood contact.
Under these conditions, local delivery of PDGF enhanced intimal thickening. (F) Vessel 14 days after injury, with local delivery of PDGF and with
barrier blockade of blood contact. Without blood contact, local delivery of PDGF had no effect upon intimal thickening or medial repopulation.
Table 1. Intimal thickening of control and hydrogel-treated rat carotid arteries 14 and 28 days after
balloon-induced injury
Group (n)* IyM† Intimal area, mm2
Significance relative
to control‡
Control, 14 days (7) 0.92 6 0.15 0.22 6 0.05
PEG-L-DA, 14 days (7) 0.09 6 0.03 0.02 6 0.01 P , 0.001
PEG-DA, 14 days (7) 0.05 6 0.02 0.01 6 0.01 P , 0.001
Control, 28 days (10) 1.13 6 0.16 0.22 6 0.03
PEG-DA, 28 days (10) 0.10 6 0.03 0.03 6 0.01 P , 0.001
Values are mean 6 SEM.
*PEG-L-DA, degradable hydrogel barrier that blocked blood contact with the artery wall for approxi-
mately 24 hr; PEG-DA, nondegradable hydrogel barrier that blocked blood contact for the duration of
the experiment. Controls were injured but not treated with a hydrogel barrier. n, Number of animals per
group.
†Ratio of the cross sectional areas of the intima and media.
‡By the Mann–Whitney U test.
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hydrogel barrier reduced intimal thickening by 95% and 91%
relative to untreated controls at 14 and 28 days. Treatment with
the degradable PEG-L-DA barrier reduced intimal thickening by
90% at 14 days. There was not a statistically significant difference
in intimal thickening for groups treated with degradable versus
nondegradable barriers (P . 0.5).
Repopulation of themedia with SMCs after injury, presumably
due to migration of SMCs from uninjured portions of the artery,
was slowed by prolonged blockade of blood contact (Table 2). At
2 days, all injured arteries were devoid of cell nuclei within the
media. In the control group, with normal exposure to blood after
injury, medial repopulation was completed by day 14 (460 medial
cells per cross-section versus 459 in control injured arteries at 28
days, and versus 516 in normal arteries without injury or treat-
ment, P. 0.2), while in groups with prolonged blockade of blood
contact, medial repopulation was still incomplete at day 28 (312
medial cells per cross-section, P , 0.05). This delay in medial
repopulation was not observed in the group treated with the
degradable PEG-L-DA barrier.
The identity of the cells participating in repopulation of the
media at 14 days was examined histologically. Virtually all cells in
the media were positive for SMC actin with no statistically
significant differences in the number of cells that were SMC
actin-negative between groups. Very few inflammatory cells were
noted in any of the groups, with no statistically significant
differences between groups. The number of SMC actin-negative
cells per cross section was 6.76 4.3 (1.4% of the total cell count)
in the control group, 5.36 3.7 (1.7%) in the PEG-DA treatment
group, and 6.46 4.7 (1.6%) in the PEG-L-DA treatment group.
The number of inflammatory cells per cross section was 0.86 6
0.90 (0.2%of the total cell count) in the control group, 0.716 1.11
(0.2%) in the PEG-DA treatment group, and 0.436 0.53 (0.1%)
in the PEG-L-DA treatment group. In no case were inflamma-
tory cells observed to be localized to the region of the hydrogel
barrier.
Several control experiments were performed to investigate any
direct influence upon arterial morphology that might have been
induced by application of a hydrogel barrier. As a control on the
possibility that the hydrogel barrier imposed nutritional limita-
tions on the artery wall, the number of cells in the media was
measured in noninjured vessels treated with a barrier for 28 days;
medial cell number did not differ from that in control noninjured
arteries (Table 2, P. 0.5). As a control on the possibility that the
interfacial photopolymerization process damaged medial SMCs,
medial cells were counted in noninjured vessels treated with a
barrier for 2 days; medial cell number did not differ from that in
control noninjured arteries (Table 2, P. 0.5). As a control on the
possibility that the photopolymerization process altered intimal
thickening, the hydrogel was formed around the periphery of
arteries after balloon injury. The extent of intimal thickening at
the 14th day and the medial cell number were not statistically
different from those in arteries that were injured but not treated
with a hydrogel in any way (intimal-to-medial area ratio of 1.066
0.12 in animals with perivascular gel versus 0.926 0.15 in control
animals,P. 0.5; and 4726 51 cells per cross-section versus 4606
43, P . 0.5; comparing control in Table 3 to 14-day controls in
Tables 1 and 2). That the hydrogel did not induce a foreign body
response is established by the lack of inflammatory cell localiza-
tion to the barrier, as described above.
Local Release of PDGF-BB and Thrombin. The potential
actions of PDGF-BB and thrombin were investigated by blocking
postinjury thrombosis with a nondegradable hydrogel barrier and
by adding back individually PDGF-BB and thrombin via local
release from a perivascular degradable hydrogel (Table 3; Fig. 1
E and F). When the injured artery was exposed to blood, local
release of PDGF-BB increased the extent of intimal thickening
approximately 2-fold (P, 0.001), demonstrating that the protein
was released in active form and at potent level. In the prolonged
absence of blood contact obtained by treatment with a nonde-
gradable barrier, the local release of PDGF-BB did not signifi-
cantly increase intimal thickening (P. 0.5) ormedial cell number
(P . 0.5). Similarly, local release of thrombin did not stimulate
intimal thickening (P . 0.5) or medial repopulation (P . 0.5).
bFGF Depletion. Balloon injury has been shown to result in
liberation of bFGF from medial stores, and this effect has been
found to be maximal at 4 days (17). bFGF levels remaining in the
vessel wall were assessed by ELISA 4 days postinjury in balloon-
injured arteries with and without blood contact, as well as in
noninjured arteries. Injury without blockade resulted in loss of
84% of medial bFGF compared with noninjured control arteries
(0.236 0.01 versus 0.046 0.01, mean OD4506 SEM normalized
Table 2. Medial repopulation of control and hydrogel-treated
arteries after balloon-induced injury
Group (n)
Number of medial
cellsycross section*
Significance
relative to
control†
Control, 2 days (4) 0 6 0
PEG-DA, 2 days (4) 0 6 0 P 5 1.0
Control, 14 days (7) 460 6 43‡
PEG-L-DA, 14 days (7) 388 6 40§ P . 0.2
PEG-DA, 14 days (7) 312 6 39¶ P , 0.05
Control, 28 days (10) 459 6 30
PEG-DA, 28 days (10) 336 6 52 P , 0.05
PEG-DA, 28 days no injury (4) 500 6 39 P . 0.1
No injury or treatment (4) 516 6 45
Values are mean 6 SEM.
*Measured by counting cell nuclei in histological sections stained with
hematoxylin and eosin.
†By the Mann–Whitney U test.
‡6.7 6 4.3 cells per cross-section were non-SMC, and 0.86 6 0.90
were inflammatory.
§6.4 6 4.7 cells per cross-section were non-SMC, and 0.43 6 0.53
were inflammatory.
¶5.3 6 3.7 cells per cross-section were non-SMC, and 0.71 6 1.11
were inflammatory.
Table 3. Effects of local delivery of PDGF and thrombin upon intimal thickening and
medial repopulation
Group (n) IyM*
Significance
relative to
control†
Number of medial
cellsycross section
Significance
relative to
control‡
Control, 14 days (7)§ 1.06 6 0.12 472 6 51
PEG-DA, 14 days (7) 0.05 6 0.02 P , 0.001 306 6 22 P , 0.05
PDGF 1 PEG-DA, 14 days (7) 0.02 6 0.01 P , 0.001 297 6 40 P , 0.05
PDGF, 14 days (7) 2.27 6 0.14 P , 0.001 495 6 25 P .0.4
Thrombin 1 PEG-DA, 14 days (7) 0.10 6 0.08 P , 0.001 282 6 39 P , 0.05
Values are mean 6 SEM.
*Ratio of the cross sectional areas of the intima and the media.
†By the Mann–Whitney U test.
‡Control was injured, not treated with hydrogel barrier, but treated with a perivascular degradable
hydrogel containing no protein.
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to total protein, P , 0.01), whereas blockade of blood contact
prevented any statistically significant liberation of bFGF (0.19 6
0.02, P . 0.5).
DISCUSSION
The objective of this study was to clarify the roles of selected
luminal and medial factors in initiating the cascade of events
leading to intimal thickening. It has been difficult in previous
experiments to unequivocally separate the roles of luminal versus
medial factors in intimal thickening, largely due to the experi-
mental challenge of completely blocking the deposition of blood
cells after injury. In the current study, we used a novel in situ
photopolymerization technique to synthesize a thin, nonthrom-
bogenic hydrogel barrier on the luminal surface of an artery. The
nondegradable intravascular hydrogel barrier was found to re-
main on the arterial wall for the full duration of these experiments
(28 days) with no change in thickness (P . 0.5). We also used a
degradable hydrogel barrier, which blocked blood contact with
the vessel wall for '24 hr. Thus, our experimental model per-
mitted separation ofmedial and luminal components on two time
scales: that of thrombosis (with the degradable barrier) and that
of SMC migration, proliferation, and matrix secretion (with the
nondegradable barrier). All experiments were performed after
removal of the adventitia, permitting clear interpretation of the
results in terms of medial and luminal activities as well as direct
delivery of bioactive agents to the media from a perivascular
depot. It should be understood that the injury model used in the
rat in this study was more severe than might be observed in
clinical balloon angioplasty, and that the artery in the clinical case
is not removed of its adventitia. It is difficult to draw extrapola-
tions between the clinical situation and this model in the rat for
numerous reasons, not the least of which is the lack of an
underlying vascular disease.
Several experiments were performed to probe the biocompat-
ibility of the hydrogel barrier, namely whether it presented
nutritional limitations to the artery wall, caused photochemical
damage during hydrogel formation or induced an inflammatory
reaction while present on the artery surface. While the hydrogel
barrier blocked blood cell deposition following injury, it is rela-
tively permeable to small-to-moderately sized proteins (19), so it
only limited exposure to thrombus derived (versus circulating)
proteins. The hydrogel barrier did not appear to interferewith the
nutritional supply of the vessel wall, as the long term presence of
the barrier did not alter the number of viable cells per cross-
section even over durations as long as 28 days.
Control experiments were performed to probe the biocom-
patibility of the interfacial photopolymerization process of hy-
drogel formation that involves the action of free radicals. When
the hydrogel barrier was applied in arteries without balloon
injury, no medial cell death was noted at 2 days, even in the
cellular layers in direct contact with the hydrogel, indicating that
the photochemical process of barrier formation was not directly
cytotoxic. This observation is in agreement with previous obser-
vations from our laboratory where we have used similar photo-
chemical manipulations to encapsulate cell aggregates within
polymeric hydrogels (18). When a hydrogel was formed perivas-
cularly after balloon injury and removal of the adventitia, no
statistically significant differences in medial cell number or inti-
mal thickening were noted. Thus, as judged from these control
experiments, the photochemical process of formation of the
hydrogel barriers did not appear to alter arterial morphology in
either the quiescent or healing state.
As a final measure of biocompatibility of the hydrogel barrier,
cellular interactions with the material were investigated. The
hydrogel barrier remained free of adherent platelets and other
blood cells throughout the 28-day duration of blood contact; thus,
no biological reaction was observed on the luminal side of the
barrier. The localized presence of inflammatory cells was inves-
tigated through Giemsa staining as well as immunohistochemical
identification of SMCs. No statistically significant differences in
the number of inflammatory cells or non-SMCs within the
arterial media were noted between the control group and those
treated with PEG-DA barriers or PEG-L-DA barriers. More-
over, no preferential localization of the inflammatory cells or
non-SMCs was noted at any site within the artery, including near
the hydrogel barrier. Thus, the presence of the hydrogel barrier
did not appear to induce any local or distributed foreign body
reaction.
It is possible that a nondegradable hydrogel barrier might have
acted exclusively as a mechanical barrier to prevent migration of
SMCs across the internal elastic lamina regardless of the bio-
chemical signals inducing SMC migration. Our hypothesis, how-
ever, is that the hydrogel barrier reduced intimal thickening by
preventing thrombosis and thus exposure to mitogenic and
chemotactic factors derived from the thrombus. To distinguish
between these two possibilities, we performed the investigation
with barriers that were present over two vastly different time
scales, one on the scale of thrombosis (PEG-L-DA, present for
'24 hr) and the other on the scale of SMC migration and
proliferation (PEG-DA, present for the duration of the 14 or 28
day experiment). If the effect on intimal thickening was the result
of blocking thrombus-derived bioactive factors, short-term block-
ade of blood contact should provide similar results with respect
to intimal thickening as permanent blockade. There was no
statistically significant difference in intimal thickening for groups
treated with degradable (90% reduction at 14 days) versus
nondegradable (95% reduction at 14 days, P . 0.2) hydrogel
barriers. This observation supports the hypothesis that the hy-
drogel barrier acts by blocking early bioactive signals derived from
thrombosis, but it does not support the alternative hypothesis that
it acted by direct blockade of SMC migration across the internal
elastic lamina. This observation also suggests that the hydrogel
barriers do not impact intimal thickening by altering the trans-
mission of hemodynamic shear stresses into the arterial wall, as
remodeling to such changes would be expected to occur over a
relatively long time period. Furthermore, the delayed medial
repopulation, i.e., the reduced cell number of the media that was
observed with PEG-DAbarrier treatment, was not observed with
PEG-L-DA barrier treatment. This suggests that the signals
necessary for efficientmedial repopulation are blood-derived, but
not necessarily entirely thrombus-derived.
Balloon-induced arterial injury consists of two components: (i)
removal of endothelial cells and (ii) stretch-induced damage to
medial SMCs. Clowes et al. (20) used a model of deendothelial-
ization without stretch injury or SMC death and demonstrated
that endothelial disruption and platelet deposition alone were
insufficient to promote intimal thickening. Our results demon-
strate that stretch injury and SMC death is likewise insufficient to
induce intimal thickening. In the absence of platelet deposition,
intimal thickening was essentially absent, presumably due to a
role played by a thrombus-associated factor such as PDGF or
thrombin. To probe this possibility with these two proteins, we
used a perivascular local release system to add back the PDGF or
thrombin that would have been supplied by the thrombus had the
hydrogel barrier been absent. If the intimal thickening response
induced by normal postinjury exposure to blood was reconsti-
tuted by local release of PDGF-BB or thrombin, then a key
causational role of that protein would be strongly supported.
Reconstitution of PDGF-BB or thrombin individually failed to
induce intimal thickening or stimulate medial repopulation when
postinjury blood contact was prohibited. In these experiments,
the adventitia was removed from the arterial wall to facilitate
diffusion of PDGF-BB and thrombin into the media (for consis-
tency, the adventitia was removed in all cases). When PDGF-BB
was delivered perivascularly after balloon injury in the normal
presence of thrombosis and blood contact, intimal thickening was
significantly exacerbated, confirming that PDGF-BB was deliv-
ered in bioactive form. While only one dose of PDGF-BB was
evaluated [that being approximately twice the amount released by
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a platelet thrombus 50 mm thick (assuming that only approxi-
mately half of the protein in the perivascular hydrogel diffuses in
the direction of the media)], the clear stimulation of intimal
thickening in the positive control suggests that the PDGF dose
examined is biologically relevant. The corresponding lack of a
response to PDGF-BB when postinjury blood contact was pro-
hibited suggests that PDGF-BB plays an important role in
stimulating intimal thickening after the cascade of events has
begun, but that it cannot initiate intimal thickening in the absence
of some other luminally derived cofactor.
We may now conclude that PDGF, although necessary, is not
sufficient to induce postinjury intimal thickening in the rat. Reidy
et al. (6) used PDGF-neutralizing antibodies to demonstrate by
depletion that PDGF plays a critical role in the intimal thickening
process. Furthermore, Nabel et al. (21) demonstrated that ex-
pression of recombinant PDGF-B in uninjured porcine iliofem-
oral arteries resulted in an 8-fold increase in intimal thickening
relative to control transfected arteries. It should be noted that in
the study by Nabel et al. (21), blood contact was permitted, and
other blood-derived factors may have been acting on the vessel
wall, especially in view of the fact that a small degree of intimal
thickening was observed in control transfected arteries. Our
results demonstrate that elevated exposure to PDGF-BB exac-
erbates neointima formation after medial injury, but only when
blood contact is permitted; some other luminally derived factor
would appear to be required in conjunction with PDGF-BB.
Similarly, locally released thrombin did not reconstitute the
effects of platelet deposition. It was not possible to locally release
thrombin in the absence of a luminal barrier, as this has been
shown to elevate platelet deposition (22). We did not simulta-
neously reconstitute PDGF and thrombin, and thus our results do
not address any possible synergy between these two factors;
evidence suggests that PDGF and thrombin may act coopera-
tively (23, 24).
From the results of this study, we may now also conclude that
the factors leading to depletion of bFGF from the media are not
intrinsic to the arterial wall. Levels of both bFGF protein and
mRNAhave been shown to decrease in response to arterial injury
and to remain low for prolonged time periods, suggesting that
bFGF is an important signal for the induction of proliferation but
not for the sustenance of proliferation (17). Blockade of blood
contact with the hydrogel barrier prevented the depletion of
bFGF from the vessel wall that is characteristically seen after
balloon injury (17), suggesting that the bFGF has remained in an
inactive form unable to act upon cell-surface receptors, and thus
unable to impact arterial healing. Given that the hydrogel barrier
is relatively permeable to moderately sized proteins (19), such as
bFGF, the reduction in bFGF depletion would not appear to be
due to mechanical entrapment of bFGF in the media by the
barrier, but rather to the absence of a signal required for bFGF
mobilization and liberation.
bFGF has been shown to be a potent stimulus for intimal
thickening, sufficient to induce it even in the absence of intimal
or medial injury (13, 25). Direct gene transfer of a plasmid
encoding a secreted form of acidic FGF caused substantial
intimal thickening in the absence of medial injury (26). bFGF
does not contain a classic signal sequence and thus is not believed
to be secreted (27), but rather leaked from damaged cells and
sequestered in the extracellular matrix. We assayed the total
amount of bFGF in the arterial wall and did not distinguish
between intracellular and extracellular bFGF.Our results suggest
that mobilization of bFGF from medial stores after vascular
injury occurs only when blood contact is permitted, and thus that
the actions of this important medial factor may be under the
control of luminal factors. This luminal factor would appear to be
thrombus-derived. Platelet heparitinase seems a plausible candi-
date; platelet heparitinase has recently been demonstrated to
release active bFGF from endothelial cell-derived extracellular
matrix in vitro (28, 29). Alternatively, thrombin has been shown
to enhance degradation of heparan sulfate by tumor cell hep-
aritinases in vitro (30), suggesting the possibility that a number of
blood-derived factors may act together. Plasmin has also been
shown to liberate active bFGF from the extracellular matrix in
vitro (31), and exposure to plasmin during spontaneous throm-
bolysis may be involved in bFGF liberation in the injured artery.
Future work will investigate the ability of blood-derived enzymes
to liberate bFGF from the vessel wall after injury in the absence
of blood contact and will determine if the liberation of bFGF is
sufficient to efficiently repopulate the media and initiate the
cascade of events leading to neointima formation.
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